Pei-Yu Chen

Endothelial TGF-β signalling drives vascular inflammation and atherosclerosis.

FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression.

FGF-dependent regulation of VEGF receptor 2 expression in mice.

FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression.

The docking protein FRS2α is a critical regulator of VEGF receptors signaling.

Fibroblast growth factor receptor 1 is a key inhibitor of TGFβ signaling in the endothelium.

Endothelial-to-mesenchymal transition drives atherosclerosis progression.

When endothelial cells go rogue.

Smooth muscle FGF/TGFβ cross talk regulates atherosclerosis progression.

Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGFβ)-dependent smooth muscle cell phenotype modulation.

Inhibition of the mTOR pathway in abdominal aortic aneurysm: implications of smooth muscle cell contractile phenotype, inflammation, and aneurysm expansion.

Fibroblast growth factor-transforming growth factor beta dialogues, endothelial cell to mesenchymal transition, and atherosclerosis.

Resilience, disease and the age of single cell science.

Smooth Muscle Cell Reprogramming in Aortic Aneurysms.

Endothelial-to-Mesenchymal Transition, Vascular Inflammation, and Atherosclerosis.